Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: May 20, 2026

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

Primary cutaneous diffuse large B-cell lymphoma, leg type: diagnostic considerations.

Alexandra C Hristov¹

¹Department of Pathology, Dermatopathology, University of Michigan, Ann Arbor, MI 48109-5602, USA. ahristov@med.umich.edu

Archives of Pathology & Laboratory Medicine

|August 2, 2012

Summary

Differentiating primary cutaneous diffuse large B-cell lymphoma, leg type, is crucial for effective treatment. This review highlights key features to distinguish it from other B-cell lymphomas.

Related Concept Videos

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Beyond Sweet Syndrome: Untangling the Threads of Histiocytoid Sweet Syndrome and Cutaneous Myeloid Neoplasia.

Surgical pathology clinics·2026

Same author

Mycoplasma pneumoniae-Induced Rash and Mucositis: Clinicopathologic Characterization of 11 Cases.

Journal of cutaneous pathology·2025

Same author

Mullerian tumor masquerading as cutaneous breast cancer.

International journal of women's dermatology·2025

Same author

Mycosis Fungoides, Sézary Syndrome, and Cutaneous B-Cell Lymphomas: 2025 Update on Diagnosis, Risk-Stratification, and Management.

American journal of hematology·2025

Same author

Expanding the use of T cell receptor beta constant 1 immunohistochemistry in formalin-fixed paraffin-embedded tissues in assessing T cell clonality in mature and immature T cell neoplasms.

Histopathology·2025

Same author

Role of single-nucleotide polymorphism microarray in the classification of BAP1-inactivated melanocytic tumours.

Histopathology·2025

Area of Science:

Dermatology
Hematopathology
Oncology

Background:

Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL-LT), presents diagnostic challenges due to overlapping features with other lymphomas.
Accurate diagnosis of PCDLBCL-LT is essential for appropriate clinical management and therapeutic decisions.

Purpose of the Study:

To comprehensively review the clinical, morphologic, and immunophenotypic characteristics of PCDLBCL-LT.
To differentiate PCDLBCL-LT from other cutaneous and systemic lymphomas, including other PCDLBCL variants, primary cutaneous follicle center lymphoma, and systemic diffuse large B-cell lymphomas.

Main Methods:

Systematic review of relevant scientific literature.
Highlighting key differentiating features for differential diagnosis.

Related Experiment Videos

Last Updated: May 20, 2026

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

Main Results:

PCDLBCL-LT exhibits distinct characteristics that allow for its differentiation from other lymphoid neoplasms.
Key distinguishing features across clinical, morphological, and immunophenotypic profiles are identified.

Conclusions:

Despite overlapping features, PCDLBCL-LT can be reliably distinguished from its differential diagnoses.
This distinction is critical for guiding patient treatment strategies and improving outcomes.